Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer

Women with hormone receptor (HR)-positive early-stage breast cancer (BC) have five-year survival rates of > 90% but remain at serious risk for developing distant metastases beyond five years from diagnosis. This retrospective cohort study used data from the Surveillance, Epidemiology, and End Res...

Descripción completa

Detalles Bibliográficos
Autores principales: Calip, Gregory S., Nabulsi, Nadia A., Hubbard, Colin, Asfaw, Alemseged A., Lee, Inyoung, Zhou, Jifang, Cueto, Jenilee, Mitra, Debanjali, Ko, Naomi Y., Hoskins, Kent F., Law, Ernest H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010392/
https://www.ncbi.nlm.nih.gov/pubmed/35226243
http://dx.doi.org/10.1007/s10552-022-01561-2

Ejemplares similares

Ejemplares similares